Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Macular Edema Following RVO
NCT01660802Phase 3Completed
- Sponsor
- Allergan
- Start
- Sep 2012
- Primary completion
- Mar 2014
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ozurdex in macular edema, sponsored by Allergan. Started Sep 2012; status: completed.
02
Drugs
ozurdex
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01660802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01660802.